Alantos Pharmaceuticals
Dynamic international biopharmaceutical company focused on developing small molecule pharmaceuticals.
Launch date
Market cap
-
Enterprise valuation
€273m (Public information from Jun 2007)
Thousand Oaks California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Debt | ||
N/A | $27.7m | Series B | |
N/A | $20.0m | Series B | |
$300m Valuation: $300m | Acquisition | ||
Total Funding | €43.4m |
Related Content
Recent News about Alantos Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.